| 1 |
33512727 | Tacrolimus (FK506) treatment protects allergen-, IL-5- and IL-13-induced mucosal eosinophilia. | 2021 Jun |
2 |
| 2 |
15598440 | FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor alpha secretion from peripheral blood mononuclear cells. | 2005 Jan 21 |
1 |
| 3 |
11093160 | The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes. | 2000 Dec |
1 |
| 4 |
7511258 | Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. | 1994 Mar 15 |
2 |
| 5 |
7691614 | Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. | 1993 Oct |
1 |
| 6 |
1705513 | The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. | 1991 Feb |
1 |
| 7 |
2483716 | T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506. | 1989 Dec |
1 |